Asaio journal (2016) published, "retrospective observational review of percutaneous cannulation for extracorporeal membrane oxygenation".The purpose of this article is to describe the approach to cannulation and its complications for patients with severe respiratory failure.It were identified 348 cannulae placed in 179 patients commenced on venovenous extracorporeal membrane oxygenation from december 2011 to march 2015.All cannulas were secured using multiple 1-0 silk ties (minimum 3points) and dressed with chlorhexidine sponge discs (biopatch; ethicon) and occlusive dressings.Cannula site infections occurred in 1.4% (5/348), all of which were managed successfully with intravenous antibiotics.The site infections were not associated with signs of systemic sepsis.There were no bloodstream infections secondary to cannula infection on cultures drawn from circuits where cannula infections were clinically apparent.
|
Integra has completed their internal investigation on january 19, 2018.Results: the units involved in the reported incidents were used during a medical study performed from 2011 to 2015 years and are not available to perform a failure analysis.Therefore, the reported condition of infection and/or dermatitis is unconfirmed.Dhr review; no device history record (dhr) was possible since no lot number was identified by the customer.Complaints history; the complaint information indicates that patients suffered ¿cannula site infection¿ during the study.Upon review of integra's complaint system from december 2015 ¿ january 16, 2018, a total of nine (9) complaints (including this one) related to infection for biopatch product family.(b)(4).Conclusion: potential root cause for ¿cannula site infection¿ cannot be determined, because it is unknown the environmental conditions where the patients were exposed during the study and, moreover, the patients¿ conditions prior to the biopatch application.Part of the recommendations for the use of the product is that the ¿biopatch should not be placed over infected wounds.¿ in addition, biopatch¿s ifu literature recognizes the possibility of adverse reactions: ¿adverse reactions to chlorhexidine gluconate such as dermatitis, hypersensitivity, and generalized allergic reactions are very rare, but if any such reactions occur, discontinue use of the dressing immediately.¿.
|